Skip to main content
Clinical Trials/NCT01823367
NCT01823367
Completed
Not Applicable

Primary Prevention of Diabetes in Children and Mothers at Increased Risk: Encourage Healthy Families.

Indiana University1 site in 1 country335 target enrollmentDecember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes Mellitus
Sponsor
Indiana University
Enrollment
335
Locations
1
Primary Endpoint
Changes in weight
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study is a randomized intervention that will test two different approaches reflecting diverse levels of both intensity and cost, to achieving risk reduction of T2D. This will help address a critical question in the translation of primary prevention research into the public health: how much intensity (and thus cost) is required to achieve an effective outcome? In addition, the proposed study will address a critical need in diabetes prevention that has not received sufficient scholarly attention: the prevention of T2D in children. No studies of diabetes prevention similar in scope to the DPP have been performed in school-aged children; however, reducing childhood obesity is widely accepted as the primary pathway to decreasing the growing prevalence of T2D in the pediatric population.

Detailed Description

The proposed interventions will target mothers with a history of Gestational Diabetes (GDM), who gave birth to babies 9 pounds or greater, or who have prediabetes who are thus at very high risk for developing diabetes, and by virtue of their GDM/prediabetes, their children are also at high risk. Because of the genetic components involved, all children born by a woman afflicted with gestational diabetes mellitus or prediabetes have elevated risk of developing Type 2 Diabetes. This first intervention builds upon the evidence-based curriculum used in the DPP and incorporates into the curriculum detailed education regarding ways to help their children adopt healthier lifestyle behaviors. It will be delivered in groups of mothers only at community sites using trained laypeople. The second intervention will use the same parent curriculum, but adds a group program for children that teach them (directly) strategies for eating better and increasing physical activity. This program will be delivered to both mothers and children in separate groups. The group sessions will take place at the same time and in the same location by a trained facilitator.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
April 27, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Marrero

J.O Ritchey Professor of Medicine. Director, Diabetes Translational Research Center

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Adult females, age 18 or greater
  • Body-mass index of ≥ 25 kg/m2
  • Is a biological mother to a child between 8 and 15 years of age (child must live with biological mom)
  • Is a biological mother with past diagnosis or history of gestational diabetes, prediabetes or gave birth to a child who weighed 9 pounds or greater at delivery
  • Child, ages 8 to 15 years, to biological mother meeting inclusion criteria for Adult Females

Exclusion Criteria

  • Biological mother or biological child with diagnosis of Type 1 or 2 Diabetes Mellitus
  • Biological mother or biological child with current A1c \> 6.5%
  • Biological mother or biological child current casual capillary blood glucose \> 220mg/dl
  • Biological mother or biological child with uncontrolled hypertension (Systolic Blood Pressure (SBP) \>180 mmHg or Diastolic Blood Pressure (DBP) \>105 mmHg)
  • Biological mother or biological child with heart attack, stroke, or transient ischemic attack in the past 6 months
  • Biological mother or biological child with chest pain, dizziness, or fainting with physical exertion
  • Biological mother or biological child with Chronic Obstructive Pulmonary Disease (COPD) or asthma requiring home oxygen
  • Biological mother or biological child with cancer treatment in the last 5 years
  • Biological mother or biological child with any other known condition that could limit ability to become physically active or limit life span to \<5 years
  • Biological mother or biological child with history of anti-diabetic medication use (oral agents or insulin) except during past gestational diabetes

Outcomes

Primary Outcomes

Changes in weight

Time Frame: 3, 6, and 12 months after the beginning of the assigned intervention program

Weight taken during data collection visits

Secondary Outcomes

  • Changes in diet(3, 6, and 12 months after the beginning of the assigned intervention program)

Study Sites (1)

Loading locations...

Similar Trials